Onconetix (ONCO) Enterprise Value (2022 - 2026)

Onconetix (ONCO) has reported Enterprise Value for 5 consecutive years, with -$3.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value fell 240.58% year-over-year to -$3.4 million in Q2 2026; TTM through Jun 2026 was -$3.4 million, a 240.58% decrease from a year earlier, with the FY2025 full-year figure at -$3.8 million, down 102.57% from the prior year.
• Enterprise Value was -$3.4 million for Q2 2026 at Onconetix, down from -$2.8 million in the prior quarter.
• Over five years, Enterprise Value peaked at $1217.8 billion in Q1 2022 and troughed at -$3.8 million in Q4 2025.
• A 5-year average of $90.3 billion and a median of $11.6 billion in 2023 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value fell 28.79% in 2023 and slumped 240.58% in 2026, its largest moves.
• Over 5 years, Enterprise Value stood at $45.9 billion in 2022, then slumped by 74.88% to $11.5 billion in 2023, then slumped by 98.73% to $146.4 million in 2024, then tumbled by 102.57% to -$3.8 million in 2025, then increased by 9.31% to -$3.4 million in 2026.
• The last three Enterprise Value figures came in at -$3.4 million (Q2 2026), -$2.8 million (Q1 2026), and -$3.8 million (Q4 2025), per Business Quant data.